119-HR679

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Last action was on 1-23-2025

Bill is currently in: House
Path to Law
House Senate President

Current status is Referred to the House Committee on Energy and Commerce.

View Official Bill Information at congress.gov

No users have voted for/against support on this bill yet. Be the first!

Detailed text is not currently available. Please wait for it to be uploaded by the United States Government.